Alaway and Blepharospasm

This page shows results related to Alaway and Blepharospasm from the FDA Adverse Event Reporting System (AERS). The adverse event Blepharospasm has been reported to the FDA a total of 2 times for Alaway.

Learn More About Alaway Adverse Events

Safety Comparison of Blepharospasm in Alaway and Related Drugs

The Proportional Reporting Ratio (PRR) for Alaway and Blepharospasm is 27. The chart below compares this proportional reporting ratio of Blepharospasm for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Blepharospasm.


NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.

People Reporting Blepharospasm Used Alaway For the Following Reasons

Of those reporting Blepharospasm, why were they taking Alaway?

Eye Pruritus

Scientific Publications on Blepharospasm

Powered by Google